Laboratories that PT MIA collaborate to provide international standard are generally overseas lab with international accreditation. Currently we work with labs from USA (Natera, Revvity, Ambry Genetics, Invitae), Singapore (Innoquest, Pathlab) and Malaysia (DNA lab).

  • Natera, USA is one of the largest non-invasive prenatal test (NIPT) providers in the world. It receives blood samples from many cities in Asia and Europe/Australia. The world-renowned lab provides services that include NIPT (Panorama and Vistara), carrier screening test (Horizon), abnormalities in products of conception after a miscarriage (Anora) and monitoring of efficiency of cancer therapy (Signatera).
  • Revvity, USA provides newborn screening test, also known as heel prick test. It is important to detect serious conditions in newborn babies so that long-term permanent damage is prevented. Congenital hypothyroidism (1 in 2,000 to 4,000 newborns) can cause slow mental development which is irreparable/permanent if undetected and untreated early. Severe combined immunodeficiency (1 in 50,000 to 1 in 100,000 newborns) should be excluded before the baby receives live, attenuated vaccines.
  • Ambry Genetics, USA performs the inherited cancer screening test.
  • Invitae, USA provides many genetic testing such as thrombophilia genes and epilepsy genes.
  • DNA lab, Malaysia can provide whole genome/exome sequencing as well as microarray tests.
  • Innoquest lab is headquartered in Singapore. The branch in Jakarta provides Singapore-standard services in the crowded lab-markets in Indonesia. In addition to routine blood test, PT MIA has access to the histopathologists in Singapore to examine tissues for accurate histopathology using the latest technology.
  • Pathlab which is headquartered in Singapore also helps to provide trustworthy services such as cervical cancer screening test (Pap smear/ThinPrep)

 

Request for uncommonly performed tests can be facilitated through PT. MIA. Examples of tests that have been performed are:

  • Karyotyping on blood sample or amniotic fluid sample.
  • Chickenpox IgG and IgM.
  • Parvovirus IgG and IgM.
  • Irregular antibodies during pregnancy.
  • Paternal confirmation of a child.